Description:
An intermediate in the synthesis of Semaglutide, an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes.
- Molecular Weight: 576.53
- Molecular Formula: C25H26N4O5.C2HF3O2
Purity: ≥98%
- Appearance: White to Off-white Powder
More details are to be found on supplier website